Talaris Therapeutics Inc

NASDAQ:TALS   3:59:52 PM EDT
7.33
+0.33 (+4.71%)
Earnings Announcements

Talaris Therapeutics Reports Q4 Loss Per Share Of $0.35

Published: 03/17/2022 20:08 GMT
Talaris Therapeutics Inc (TALS) - Talaris Therapeutics Announces Fourth Quarter and Year-end Financial Results.
Q4 Loss per Share $0.35.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.46

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.49

More details on our Analysts Page.